Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Taylor et al./Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Gosmanov et al

The Nurse's Health Study (NHS) I (2) suggests a protective effect for ACE inhibitors, since the risk of diabetes is higher for patients on thiazides, β-blockers, "other" antihypertensives, and CCBs. The lack of prospective clinical trials evaluating the incidence of diabetes as a prim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2006-10, Vol.29 (10), p.2334
Hauptverfasser: Gosmanov, Aidar R, Connelly, Stephanie, Lewis, James B, Gosmanov, Niyaz R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 10
container_start_page 2334
container_title Diabetes care
container_volume 29
creator Gosmanov, Aidar R
Connelly, Stephanie
Lewis, James B
Gosmanov, Niyaz R
description The Nurse's Health Study (NHS) I (2) suggests a protective effect for ACE inhibitors, since the risk of diabetes is higher for patients on thiazides, β-blockers, "other" antihypertensives, and CCBs. The lack of prospective clinical trials evaluating the incidence of diabetes as a primary end point and the absence of placebo-controlled studies leaves physicians wondering whether a particular antihypertensive medication causes or prevents diabetes.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_223034355</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1144575431</sourcerecordid><originalsourceid>FETCH-proquest_journals_2230343553</originalsourceid><addsrcrecordid>eNq1jbsOgkAQRbfQRHz8w8QeXXkkYmd8FzaE3qwyhFXcRWYg8ff8Mkn0A2ysbnHuyekIR86CyA2jyOuJPtFVShkE87kjXkvDOn-WWDEa0g3CEVN9UaytIVAmBc4RYk03sBkczEWnaBiS1gAP1lqdkZEWECOVrYHAFhL1LGwFyKCKyfQPgZ2luzK2-SSGopupgnD03YEYbzfJau-WlX3USHy62royLTp5ni_9wA9D_6fTG6JCZqY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223034355</pqid></control><display><type>article</type><title>Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Taylor et al./Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Gosmanov et al</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Gosmanov, Aidar R ; Connelly, Stephanie ; Lewis, James B ; Gosmanov, Niyaz R</creator><creatorcontrib>Gosmanov, Aidar R ; Connelly, Stephanie ; Lewis, James B ; Gosmanov, Niyaz R</creatorcontrib><description>The Nurse's Health Study (NHS) I (2) suggests a protective effect for ACE inhibitors, since the risk of diabetes is higher for patients on thiazides, β-blockers, "other" antihypertensives, and CCBs. The lack of prospective clinical trials evaluating the incidence of diabetes as a primary end point and the absence of placebo-controlled studies leaves physicians wondering whether a particular antihypertensive medication causes or prevents diabetes.</description><identifier>ISSN: 0149-5992</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>Alexandria: American Diabetes Association</publisher><subject>ACE inhibitors ; Diabetes ; Diuretics ; Drug therapy ; Hospitals ; Hypertension ; Medicine ; Womens health</subject><ispartof>Diabetes care, 2006-10, Vol.29 (10), p.2334</ispartof><rights>Copyright American Diabetes Association Oct 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Gosmanov, Aidar R</creatorcontrib><creatorcontrib>Connelly, Stephanie</creatorcontrib><creatorcontrib>Lewis, James B</creatorcontrib><creatorcontrib>Gosmanov, Niyaz R</creatorcontrib><title>Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Taylor et al./Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Gosmanov et al</title><title>Diabetes care</title><description>The Nurse's Health Study (NHS) I (2) suggests a protective effect for ACE inhibitors, since the risk of diabetes is higher for patients on thiazides, β-blockers, "other" antihypertensives, and CCBs. The lack of prospective clinical trials evaluating the incidence of diabetes as a primary end point and the absence of placebo-controlled studies leaves physicians wondering whether a particular antihypertensive medication causes or prevents diabetes.</description><subject>ACE inhibitors</subject><subject>Diabetes</subject><subject>Diuretics</subject><subject>Drug therapy</subject><subject>Hospitals</subject><subject>Hypertension</subject><subject>Medicine</subject><subject>Womens health</subject><issn>0149-5992</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNq1jbsOgkAQRbfQRHz8w8QeXXkkYmd8FzaE3qwyhFXcRWYg8ff8Mkn0A2ysbnHuyekIR86CyA2jyOuJPtFVShkE87kjXkvDOn-WWDEa0g3CEVN9UaytIVAmBc4RYk03sBkczEWnaBiS1gAP1lqdkZEWECOVrYHAFhL1LGwFyKCKyfQPgZ2luzK2-SSGopupgnD03YEYbzfJau-WlX3USHy62royLTp5ni_9wA9D_6fTG6JCZqY</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>Gosmanov, Aidar R</creator><creator>Connelly, Stephanie</creator><creator>Lewis, James B</creator><creator>Gosmanov, Niyaz R</creator><general>American Diabetes Association</general><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20061001</creationdate><title>Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Taylor et al./Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Gosmanov et al</title><author>Gosmanov, Aidar R ; Connelly, Stephanie ; Lewis, James B ; Gosmanov, Niyaz R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_2230343553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>ACE inhibitors</topic><topic>Diabetes</topic><topic>Diuretics</topic><topic>Drug therapy</topic><topic>Hospitals</topic><topic>Hypertension</topic><topic>Medicine</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gosmanov, Aidar R</creatorcontrib><creatorcontrib>Connelly, Stephanie</creatorcontrib><creatorcontrib>Lewis, James B</creatorcontrib><creatorcontrib>Gosmanov, Niyaz R</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gosmanov, Aidar R</au><au>Connelly, Stephanie</au><au>Lewis, James B</au><au>Gosmanov, Niyaz R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Taylor et al./Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Gosmanov et al</atitle><jtitle>Diabetes care</jtitle><date>2006-10-01</date><risdate>2006</risdate><volume>29</volume><issue>10</issue><spage>2334</spage><pages>2334-</pages><issn>0149-5992</issn><coden>DICAD2</coden><abstract>The Nurse's Health Study (NHS) I (2) suggests a protective effect for ACE inhibitors, since the risk of diabetes is higher for patients on thiazides, β-blockers, "other" antihypertensives, and CCBs. The lack of prospective clinical trials evaluating the incidence of diabetes as a primary end point and the absence of placebo-controlled studies leaves physicians wondering whether a particular antihypertensive medication causes or prevents diabetes.</abstract><cop>Alexandria</cop><pub>American Diabetes Association</pub></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2006-10, Vol.29 (10), p.2334
issn 0149-5992
language eng
recordid cdi_proquest_journals_223034355
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects ACE inhibitors
Diabetes
Diuretics
Drug therapy
Hospitals
Hypertension
Medicine
Womens health
title Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Taylor et al./Antihypertensive Medications and the Risk of Incident Type 2 Diabetes: Response to Gosmanov et al
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A07%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antihypertensive%20Medications%20and%20the%20Risk%20of%20Incident%20Type%202%20Diabetes:%20Response%20to%20Taylor%20et%20al./Antihypertensive%20Medications%20and%20the%20Risk%20of%20Incident%20Type%202%20Diabetes:%20Response%20to%20Gosmanov%20et%20al&rft.jtitle=Diabetes%20care&rft.au=Gosmanov,%20Aidar%20R&rft.date=2006-10-01&rft.volume=29&rft.issue=10&rft.spage=2334&rft.pages=2334-&rft.issn=0149-5992&rft.coden=DICAD2&rft_id=info:doi/&rft_dat=%3Cproquest%3E1144575431%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223034355&rft_id=info:pmid/&rfr_iscdi=true